Organisatie
Hematologie
Huidige onderzoekers
1 - 10 of 18 results
- Fatema Afennas (Lid)
- Veerle Beckers (Lid)
- Charlotte Caron (Lid)
- Ludwine Antoinette Claeys (Lid)
- Ann De Becker (Lid)
- Nathan De Beule (Lid)
- Inke De Haes (Lid)
- Sylvia Faict (Lid)
- Karel Fostier (Lid)
- Kristin Jochmans (Lid)
Projecten
1 - 1 of 1
- Tumor karakterisatie en ziekteopvolging in multipel myeloom door (epi) genetische typering gebruik makend van liquid biopsiesVanaf1 nov 2021 → HedenFinanciering: FWO junior postdoctoraal mandaat
Publicaties
41 - 50 van 79
- Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Auteurs: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pagina's: 112-121 - Assessing the performance of maternity care in Europe(2015)
Auteurs: Ramón Escuriet, Joanna White, Katrien Beeckman, Lucy Frith, Fatima Leon-Larios, Christine Loytved, Ans Luyben, Marlene Sinclair, Edwin van Teijlingen
- Predictors of late initiation for prenatal care in a metropolitan region in Belgium. A cohort study(2015)
Auteurs: Maaike Fobelets, Katrien Beeckman, Annemarie Hoogewys, Mieke Embo, Ronald Buyl, Koen Putman
Pagina's: 648-654 - Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice(2019)
Auteurs: Patrick Tjok Joe, Ioanna Christopoulou, Lien van Hoecke, Bert Schepens, Tine Ysenbaert, Carlo Heirman, Kris Thielemans, Xavier Saelens, Joeri L Aerts
- Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Auteurs: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pagina's: 249-255 - Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used(2018)
Auteurs: Xavier Bossuyt, Michel Delforge, Martin Reynders, Doreen Dillaerts, Ben Sprangers, Karel Fostier, Koen Poesen, Martine Vercammen
Pagina's: 1815-1818 - Exosomal Communication in Multiple Myeloma: Friend or Foe(2019)
Auteurs: Sylvia Faict, Eline Menu
- Lymphoma-like monoclonal B cell lymphocytosis in a patient population(2018)
Auteurs: Sam Vander Meeren, Bert Heyrman, Wim Renmans, M.H.C. Bakkus, Brigitte Maes, Hendrik De Raeve, Henri Schots, Kristin Jochmans
Pagina's: 1219-1227 - Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Auteurs: Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, et al.
Pagina's: 45 - Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism(2023)
Auteurs: Hatice Satilmis, Emma Verheye, Philip Vlummens, Inge Oudaert, Niels Vandewalle, Rong Fan, Jennifer M Knight, Nathan De Beule, Gamze Ates, Ann Massie, et al.
Pagina's: 69–80